Bio & Pharma
Kwangdong Pharma acquires stake in Precision Bio
The company purchases a 29.7% stake in-vitro diagnostic device company for $12 mn
By Jul 03, 2024 (Gmt+09:00)
1
Min read
Most Read
S.Korea's LS Materials set to boost earnings ahead of IPO process
NPS to cut global stocks under GP management, up its direct control
Korean PE funds shrink in 2023 for first time in 7 years
AI to drive Mirae Asset's next-phase growth: chairman
Cosmax mulls building cosmetics factory in Latin America
South Korea's Kwangdong Pharmaceutical announced on Tuesday that it signed a stock purchase agreement to acquire Precision Biosensor Inc., a company specializing in in-vitro diagnostic devices.
Precision Bio manufactures and sells diagnostic devices and cartridges for both human and animal use.
Kwangdong Pharmaceutical stated that it plans to acquire a 29.7% stake in Precision Bio from its largest shareholder, i-SENS Inc., and others. The acquisition amount is 17 billion won ($12.2 million).
Kwangdong Pharmaceutical explained that the purpose of this stock acquisition is to build infrastructure for entering the personalized healthcare business.
Write to Jeong Min Nam at peux@hankyung.com
More to Read
-
Bio & PharmaKwangdong to sell exclusively three global rare disease drugs
Jul 24, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaKwangdong introduces new drug candidate for pediatric myopia
Mar 27, 2023 (Gmt+09:00)
1 Min read
Comment 0
LOG IN